UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse

Selikhova, M; Tripoliti, E; Fedoryshyn, L; Matvienko, Y; Stanetska, H; Boychuk, M; Komnatska, I; ... Sanotsky, Y; + view all (2016) Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse. Clinical Neurology and Neurosurgery , 147 pp. 71-77. 10.1016/j.clineuro.2016.05.027. Green open access

[thumbnail of Lees_Ephedronic.dysarthria.revision27.2.pdf]
Preview
Text
Lees_Ephedronic.dysarthria.revision27.2.pdf - Accepted Version

Download (783kB) | Preview

Abstract

INTRODUCTION: In the last fifteen years a new cause of chronic manganese toxicity has been recognized. It follows recreational intravenous injections of Ephedrone, synthesized from a cold remedies contained pseudoephedrine. Potassium permanganate is used as an oxidant. It presents with severe parkinsonism-dystonia and a characteristic dysarthria. OBJECTIVES: We performed a focus perceptual study of dysarthria in Ephedrone induced parkinsonism and compared the findings with the speech disorders seen in Parkinson's disease (PD) and Progressive Supranuclear Palsy (PSP). METHODS: A digital voice recording, perceptual speech analysis (Darley, 1975) [18], serial neurological assessment and Brain Magnetic Resonance (MR) imaging were performed at the Lviv regional Clinical Hospital. The results were analysed at the Institute of Neurology in London. RESULTS: Dysarthria developed after 8.5 ± 3.2 months of daily intravenous Ephedrone abuse and was an initial symptom in a third of cases. It was characterised by a robotic-flat prosody, whispering or continuous phonation, an inability to regulate pitch and volume, frozen lip articulation, a variable degree of dystonic tightness, difficulties in speech initiation and palladia, There was no nasality and swallowing was normal. In some patients speech deteriorated even after the discontinuation of Ephedrone. MR imaging, performed soon after drug cessation showed T1 signal hyperintesity in striatum and pallidum, especially in the Globus Pallidum interna. CONCLUSION: Ephedrone induced chronic manganese toxicity can lead to a mixed hypokinetic-dystonic dysarthria with a distinct dystonic pattern. Perceptual speech analysis can be a helpful ancillary investigation in the differential diagnosis of parkinsonism, and may permit the recognition of chronic manganese toxicity.

Type: Article
Title: Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.clineuro.2016.05.027
Publisher version: http://dx.doi.org/10.1016/j.clineuro.2016.05.027
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Surgery, Neurosciences & Neurology, Parkinsonism, Dysarthria, Manganism, Globus pallidum, DEEP BRAIN-STIMULATION, PARKINSONS-DISEASE, HEPATIC CIRRHOSIS, BASAL GANGLIA, DYSARTHRIA, DYSTONIA, ENCEPHALOPATHY, MOVEMENT, EXPOSURE, FEATURES
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
URI: https://discovery.ucl.ac.uk/id/eprint/10056999
Downloads since deposit
211Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item